Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype

by Zagros on October 15, 2020

PR Newswire    ”Press Releases US - English ”

CARLSBAD, Calif. ,  Oct. 15  /PRNewswire/ -  Shrink Nanotechnologies, Inc.  (“Shrink”) (OTC Bulletin Board: INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool. Shrink expects to begin offering this product for sale in the latter part of 2010.



“Tissue engineering and cell culturing are high growth areas of the biotechnology field. This trend is being fueled as the idea of ‘personalized medicine’ or ‘therapeutics and treatments made for you’ - becomes a reality. And as the personalized medicine movement grows, biotech and pharmaceutical companies are focusing on the promise of novel research, especially new cellular-based therapies, to help combat cancer, spinal cord injuries, diabetes, Parkinson’s and Alzheimer’s disease, and many more. StemDisc is a platform for Shrink to offer a growing suite of products that will address an important spectrum of the needs within cellular and tissue engineering technologies and tools,”  Mark L. Baum , CEO of  Shrink Nanotechnologies, Inc.

“We have started field testing of our first StemDisc450 prototypes, and we anticipate being able to show time lapse videos of this product performing, and actually developing HESCs (human embryonic stem cells) and IPSCs (induced pluripotent stem cells),” added Baum. “Shrink is exploring opportunities with established stem cell R&D companies for potential strategic partnerships for the sale and marketing of StemDisc products. Our primary target market is the more than 3,000 stem cell research labs and 15,000 biomedical laboratories operating in  the United States .”

About StemDisc

StemDisc is designed to improve embryoid body (EB) formation of stem cells at a higher rate and efficiency over current EB formation methods. The platform can be used to grow and differentiate human and animal single cells, human embryonic stem cells (HESCs) and induced pluri-potent stem cells (IPSCs). Versions of StemDisc’s unique honeycomb-like well will be offered in different diameter and depth depending on the type of cell and application. Each round bottom “microwell” is capable of making 800 to 1,000 EBs, increasing the flexibility of use for researchers to achieve optimum EB formation with high reliability compared to legacy methods. A unique feature of the StemDisc product line is the optical transparency of the surface that the cells rest in. The StemDisc polymer offers amazing transparency, providing the cell biologist with the ability to see more of what she is doing as she completes her research. StemDisc’s five micron walls between microwells virtually assure a clean transfer of the biological material into a well in a few easy steps, helping to further lower costs and accelerate the time to publish results of potentially life-saving studies. If you are interested in receiving more information about StemDisc, please contact us by visiting

Your Penny Stock News Destination

Cancer Month

{ 1 trackback }

Penny’s for Penny Trading | StockTalkNews
October 19, 2020 at 4:23 pm

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: